These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 34628032)

  • 1. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models.
    Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid acid induced 16 deficiency aggravates colitis and colitis-associated tumorigenesis in mice.
    Xu YL; Ding CL; Qian CL; Qi ZT; Wang W
    Cell Death Dis; 2019 Dec; 10(12):958. PubMed ID: 31862898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer.
    Sharp SP; Malizia RA; Walrath T; D'Souza SS; Booth CJ; Kartchner BJ; Lee EC; Stain SC; O'Connor W
    Gene; 2018 Nov; 677():299-307. PubMed ID: 30121380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGR1 (GPR68) and TDAG8 (GPR65) Have Antagonistic Effects in Models of Colonic Inflammation.
    Perren L; Busch M; Schuler C; Ruiz PA; Foti F; Weibel N; de Vallière C; Morsy Y; Seuwen K; Hausmann M; Rogler G
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of Factor-Inhibiting HIF (
    Schützhold V; Gravemeyer J; Bicker A; Hager T; Padberg C; Schäfer J; Wrobeln A; Steinbrink M; Zeynel S; Hankeln T; Becker JC; Fandrey J; Winning S
    J Immunol; 2022 Mar; 208(5):1280-1291. PubMed ID: 35121641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal epithelial pH-sensing receptor GPR65 maintains mucosal homeostasis via regulating antimicrobial defense and restrains gut inflammation in inflammatory bowel disease.
    Li G; Lin J; Gao X; Su H; Lin R; Gao H; Feng Z; Wu H; Feng B; Zuo K; Li Y; Wu W; Fang L; Liu Z
    Gut Microbes; 2023 Dec; 15(2):2257269. PubMed ID: 37749885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Interplay Between Innate Immunity (TLR-4) and sCD40L in the Context of an Animal Model of Colitis-associated Cancer.
    Angelou A; Papalois AE; Antoniou E; Wang J; Amini N; Pikouli A; Andreatos N; Buettner S; Munir M; Theodoropoulos G; Zografos GC; Sarantis P; Pulvirenti A; Kamphues C; Theocharis S; Pikoulis E; Margonis GA
    Anticancer Res; 2020 Oct; 40(10):5457-5462. PubMed ID: 32988867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel Disease.
    Tcymbarevich I; Richards SM; Russo G; Kühn-Georgijevic J; Cosin-Roger J; Baebler K; Lang S; Bengs S; Atrott K; Bettoni C; Gruber S; Frey-Wagner I; Scharl M; Misselwitz B; Wagner CA; Seuwen K; Rogler G; Ruiz PA; Spalinger M; de Vallière C
    J Crohns Colitis; 2019 Feb; 13(2):245-258. PubMed ID: 30535144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Cell-Specific CerS4 Depletion Prolonged Inflammation and Enhanced Tumor Burden in the AOM/DSS-Induced CAC Model.
    El-Hindi K; Brachtendorf S; Hartel JC; Oertel S; Birod K; Merz N; Trautmann S; Thomas D; Weigert A; Schäufele TJ; Scholich K; Schiffmann S; Ulshöfer T; Utermöhlen O; Grösch S
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.
    Wei X; Liang J; Liu J; Dai Y; Leng X; Cheng Y; Chi L
    J Ethnopharmacol; 2024 May; 326():117995. PubMed ID: 38428656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis.
    Hidalgo-García L; Ruiz-Malagon AJ; Huertas F; Rodríguez-Sojo MJ; Molina-Tijeras JA; Diez-Echave P; Becerra P; Mirón B; Morón R; Rodríguez-Nogales A; Gálvez J; Rodríguez-Cabezas ME; Anderson P
    Pharmacol Res; 2023 Sep; 195():106891. PubMed ID: 37586618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor-β protects against colitis-associated neoplasia in mice.
    Saleiro D; Murillo G; Benya RV; Bissonnette M; Hart J; Mehta RG
    Int J Cancer; 2012 Dec; 131(11):2553-61. PubMed ID: 22488198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR4 deficiency alleviates intestinal inflammation in a mouse model of acute experimental colitis.
    Sanderlin EJ; Leffler NR; Lertpiriyapong K; Cai Q; Hong H; Bakthavatchalu V; Fox JG; Oswald JZ; Justus CR; Krewson EA; O'Rourke D; Yang LV
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):569-584. PubMed ID: 27940273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy.
    Sheng YH; Giri R; Davies J; Schreiber V; Alabbas S; Movva R; He Y; Wu A; Hooper J; McWhinney B; Oancea I; Kijanka G; Hasnain S; Lucke AJ; Fairlie DP; McGuckin MA; Florin TH; Begun J
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):33-53. PubMed ID: 32497793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Gut Microbiota Combined with Upregulation of Intestinal Tight Junction Explains Anti-Inflammatory Effect of Corylin on Colitis-Associated Cancer in Mice.
    Chang ZY; Liu HM; Leu YL; Hsu CH; Lee TY
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury.
    Shi C; Liang Y; Yang J; Xia Y; Chen H; Han H; Yang Y; Wu W; Gao R; Qin H
    PLoS One; 2013; 8(6):e66814. PubMed ID: 23826144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 4 prevents AOM/DSS-induced colitis-associated colorectal cancer in Bacteroides fragilis gnotobiotic mice.
    Lee YP; Huang WC; Lin TJ; Chiu CC; Wang YC; Chen YH; Hung SW; Chuang HL; Chen TH
    Hum Exp Toxicol; 2021 Apr; 40(4):622-633. PubMed ID: 32924602
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.
    Markov AV; Savin IA; Zenkova MA; Sen'kova AV
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer.
    Chartier LC; Howarth GS; Trinder D; Mashtoub S
    Carcinogenesis; 2021 Feb; 42(2):202-209. PubMed ID: 32940671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.